Page last updated: 2024-08-21

isoxazoles and Intestinal Diseases

isoxazoles has been researched along with Intestinal Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Anderson, AL; Balasubramaniyan, N; D'Alessandro, A; Devereaux, MW; El Kasmi, KC; Ghosh, S; Orlicky, DJ; Shearn, CT; Sokol, RJ; Suchy, FJ1
Cecen, S; Demir, EM; Ergin, K; Kose, H; Serter, M; Yildiz, Y1
Araki, E; Ichiki, T; Katsuta, T; Kodama, R; Masunaga, A; Ohkubo, M; Yamashita, K1

Other Studies

3 other study(ies) available for isoxazoles and Intestinal Diseases

ArticleYear
Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; Bile Acids and Salts; Cholestasis; Gene Expression; Gene Expression Regulation; Hepatocytes; Interleukin-1beta; Intestinal Diseases; Isoxazoles; Lipoproteins; Liver Diseases; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Parenteral Nutrition; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Signal Transduction

2022
Protective effects of leflunomide on intestinal ischemia-reperfusion injury: leflunomide against intestinal ischemia-reperfusion.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Intestinal Diseases; Intestinal Mucosa; Isoxazoles; Leflunomide; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Treatment Outcome

2010
[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in beagle dogs].
    The Journal of toxicological sciences, 1990, Volume: 15 Suppl 2

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dogs; Female; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Isoxazoles; Male; Ulcer

1990